PPAR Agonists, Compounds, Pharmaceutical Compositions, and Methods of Use Thereof

Spin Trapping Pharmaceutical Compositions and Methods for Use Thereof

Pharmaceutical Preparations of Glutathone and Methods of Administration Thereof

format=htm Oct. 22, 1999. Baldwin, A.S., “The NF-kappa B and I kappa B proteins: new discoveries and insights', .../wgetcitjournal=Annu Rev+Immunol&volume=14&page=649&display= abstract&format=h Oct. 29, 1999.format=h Oct. 29, 1999. Barcellos-Hoff, M.H., et al., “Redox-mediated activation of latent transforming growth factor-betal, http://endo.edoc .com/volumes/mend/vol-10.09/1077.html. PEDF-S. ...

Safety of PPAR Agonists

The thiazolidinediones pioglitazone and rosiglitazone were introduced into global markets in 1999–2000; we now have over 10 years of experience with them. The safety issues that it was fashionable to focus on at that time were abnormalities of liver function as a result of the rare but serious side effects of troglitazone, the thiazolidinedione then on the market. This turned out to be irrelave...

PBN, DMPO, and POBN Compositions and Method of Use Thereof for Inhibition of Age-Associated Oxidation

Neuronal Cell Model and Methods of Use Thereof